Stocktoria
VALHI INC /DE/ VHI
NYSE · stock · Industrial Inorganic Chemicals · website · IPO 1980-03-17
VALHI INC /DE/ financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.1B | $2.1B | $1.9B | $2.2B | $2.3B | $1.8B | $1.9B | $1.8B | $1.9B | $1.5B |
| Gross profit | $295.4M | $424.5M | $245.2M | $490.4M | $580.2M | $412.1M | $434.6M | $609.2M | $612.9M | $307.9M |
| R&D expense | $17.0M | $14.0M | $18.0M | $16.0M | $17.0M | $16.0M | $17.0M | $16.0M | $19.0M | $13.0M |
| SG&A expense | $312.3M | $256.2M | $277.4M | $304.0M | $311.9M | $283.6M | $294.2M | $310.0M | $262.6M | $232.6M |
| Operating income | $63.3M | $210.7M | $34.2M | $239.4M | $318.6M | $186.1M | $192.7M | $370.7M | $380.3M | $119.2M |
| Interest expense | $57.1M | $49.9M | $28.3M | $27.9M | $32.5M | $36.2M | $40.8M | $55.7M | $58.9M | $58.1M |
| Income tax | $11.9M | $82.9M | -$24.6M | $36.8M | $60.1M | $15.9M | $26.5M | -$30.7M | -$120.0M | $18.6M |
| Net income | -$57.6M | $108.0M | -$9.9M | $87.2M | $127.2M | $55.2M | $49.2M | $262.2M | $207.5M | -$15.9M |
| EPS (diluted) | $-2.02 | $3.79 | $-0.35 | $3.06 | $4.46 | $1.94 | $1.73 | — | — | — |
| Operating cash flow | -$35.5M | $44.0M | $3.9M | $34.9M | $459.7M | $152.2M | $177.2M | $165.5M | $259.3M | $79.8M |
| Free cash flow | -$82.1M | $13.1M | -$44.6M | -$32.7M | $395.6M | $86.7M | $117.3M | $104.1M | $188.0M | $20.9M |
| Cash & equivalents | $214.0M | $348.3M | $407.0M | $478.5M | $698.4M | $518.6M | $523.8M | $499.8M | $435.7M | $159.7M |
| Inventory | $659.8M | $685.8M | $596.1M | $640.8M | $458.7M | $538.2M | $522.1M | $515.8M | $398.4M | $359.2M |
| Total assets | $2.6B | $2.8B | $2.7B | $2.8B | $3.0B | $2.9B | $2.8B | $2.7B | $2.9B | $2.4B |
| Shareholders' equity | $1.4B | $1.4B | $1.3B | $1.3B | $1.2B | $1.0B | $980.1M | $989.0M | $766.7M | $444.4M |
Growth · year-over-year · Revenue CAGR 3.5%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | -1.3% | +9.5% | -13.5% | -3.2% | +24.1% | -2.5% | +4.3% | -3.2% | +23.7% | +2.1% |
| Net income growth | -153.3% | — | -111.4% | -31.4% | +130.4% | +12.2% | -81.2% | +26.4% | — | — |
| EPS growth | -153.3% | — | -111.4% | -31.4% | +129.9% | +12.1% | — | — | — | — |
| Free cash flow growth | -726.7% | — | — | -108.3% | +356.3% | -26.1% | +12.7% | -44.6% | +799.5% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.